World Asset Management’s GSK GSK Stock Holding History

World Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,945	Closed	-$897K	–	822
2020 Q1	$897K	Hold	18,945	–	–	0.08%	242
2019 Q4	$1.11M	Sell	18,945 -5,100	-21%	-$284K	0.05%	353
2019 Q3	$1.28M	Sell	24,045 -4,776	-17%	-$246K	0.06%	312
2019 Q2	$1.44M	Sell	28,821 -1,203	-4%	-$60.4K	0.07%	290
2019 Q1	$1.57M	Hold	30,024	–	–	0.08%	249
2018 Q4	$1.43M	Sell	30,024 -20,459	-41%	-$1.01M	0.09%	229
2018 Q3	$2.54M	Sell	50,483 -8,984	-15%	-$456K	0.12%	178
2018 Q2	$3M	Sell	59,467 -19,445	-25%	-$979K	0.15%	150
2018 Q1	$3.85M	Sell	78,912 -32,294	-29%	-$1.5M	0.18%	116
2017 Q4	$4.93M	Sell	111,206 -4,348	-4%	-$201K	0.17%	132
2017 Q3	$5.86M	Sell	115,554 -300	-0.3%	-$15.2K	0.19%	108
2017 Q2	$6.25M	Sell	115,854 -5,844	-5%	-$312K	0.22%	93
2017 Q1	$6.41M	Buy	121,698 +1,920	+2%	+$97.4K	0.21%	100
2016 Q4	$5.77M	Sell	119,778 -10,586	-8%	-$523K	0.22%	91
2016 Q3	$7.03M	Buy	130,364 +9,775	+8%	+$536K	0.25%	76
2016 Q2	$6.53M	Buy	120,589 +9,267	+8%	+$488K	0.25%	78
2016 Q1	$5.64M	Buy	111,322 +8,034	+8%	+$400K	0.23%	87
2015 Q4	$5.21M	Buy	103,288 +2,378	+2%	+$121K	0.2%	106
2015 Q3	$4.85M	Buy	100,910 +8,188	+9%	+$426K	0.2%	99
2015 Q2	$4.83M	Sell	92,722 -6,030	-6%	-$340K	0.19%	118
2015 Q1	$5.7M	Sell	98,752 -858	-0.9%	-$49.2K	0.2%	109
2014 Q4	$5.32M	Sell	99,610 -734	-0.7%	-$41.1K	0.18%	117
2014 Q3	$5.77M	Sell	100,344 -5,526	-5%	-$339K	0.17%	121
2014 Q2	$7.08M	Sell	105,870 -3,542	-3%	-$240K	0.22%	93
2014 Q1	$7.31M	Sell	109,412 -12,622	-10%	-$853K	0.23%	89
2013 Q4	$8.14M	Sell	122,034 -41,060	-25%	-$2.66M	0.23%	89
2013 Q3	$10.2M	Sell	163,094 -33,633	-17%	-$2.17M	0.26%	71
2013 Q2	$12.3M	Buy	+196,727	New	+$12.5M	0.29%	64

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

World Asset Management's GSK Position: Q2 2020 in Review

World Asset Management sold out of GSK (GSK) in Q2 2020, closing a stake of 18,945 shares — an estimated $897K sold.

World Asset Management first reported a position in GSK in Q2 2013 and held it in 28 quarters. The position peaked at $12.3M in Q2 2013. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

World Asset Management reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
World Asset Management sold 18,945 GSK shares in Q2 2020, an estimated $897K.
World Asset Management first reported a position in GSK in Q2 2013 and held it in 28 quarters.
World Asset Management's GSK position peaked at $12.3M in Q2 2013.
840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on World Asset Management's 13F filing for Q2 2020, filed 24 Jul 2020.